Skip to main content
BICO Group logo

BICO Group — Investor Relations & Filings

Ticker · BICO ISIN · SE0013647385 LEI · 549300FE4PT8NDXXNK85 ST Manufacturing
Open in API
Filings indexed 239 across all filing types
Latest filing 2021-03-12 Major Shareholding Noti…
Country SE Sweden
Listing ST BICO

About BICO Group

http://bico.com

BICO Group is a bioconvergence company that provides technologies and solutions for laboratory automation in the life sciences. Integrating biology, engineering, and digital technologies, the company aims to accelerate innovation and automate the lab of the future. BICO offers a portfolio of hardware, software, and services across two business areas: Lab Automation and Life Science Solutions. Its products, including bioprinting technologies, are designed to enhance research efficiency and accuracy for pharmaceutical and biotechnology clients. By automating labor-intensive tasks, the solutions generate standardized, high-quality data, which supports data-driven decision-making and the application of artificial intelligence and machine learning in research and development.

Recent filings

Filing Released Lang Actions
Major Shareholding Notification 2021
Major Shareholding Notification Classification · 1% confidence The document details a change in shareholding and voting rights for an individual ('Erik Gatenholm') in BICO Group AB. It explicitly states the 'Reason for major shareholding notification' and provides 'Before the transaction' and 'After the transaction' figures for shares and voting rights, including percentages. This structure perfectly matches the definition of a Major Shareholding Notification, which corresponds to the filing code MRQ.
2021-03-12 English
CELLINK AB announces the completion of the offering of Senior Unsecured Convertible Bonds convertible into Class B shares and a Class B share issue in an overall amount of SEK 3.0 billion
Capital/Financing Update Classification · 1% confidence The document is a formal announcement by CELLINK AB regarding the pricing and completion of a capital raise involving both Senior Unsecured Convertible Bonds and a directed issue of new Class B shares. It details the use of proceeds, terms of the bonds, dilution effects, and the involvement of financial institutions. This falls squarely under the definition of a capital/financing update as it describes specific fundraising activities and changes to the company's capital structure.
2021-03-12 English
CELLINK AB offentliggör utfall av erbjudandet av Seniora Icke-Säkerställda Konvertibla Skuldebrev med konvertering till B-aktier och emissionen av B-aktier till totalt belopp om 3 miljarder kr
Share Issue/Capital Change Classification · 1% confidence The document is a press release from CELLINK AB dated March 12, 2021, announcing the final outcome of a significant financing event. Specifically, it details the pricing and completion of an offering involving Senior Unsecured Convertible Bonds (Konvertiblerna) totaling SEK 1.5 billion and a directed new share issue (Nyemissionen) totaling SEK 1.5 billion. The text discusses the use of proceeds (financing an acquisition), key terms of the bonds (conversion price, interest, redemption), dilution effects, and the need for a future shareholder resolution (Aktieägarbeslut) regarding the conversion rights. This content clearly relates to fundraising, capital structure changes, and the issuance of new securities. This aligns directly with the definition of 'Capital/Financing Update' (CAP). It is not a full annual report (10-K), an earnings release (ER), or a simple announcement of a report (RPA/RNS), as it contains the substantive details of the transaction itself.
2021-03-12 Swedish
CELLINK AB (publ) offentliggör ett erbjudande av Seniora Icke-Säkerställda Konvertibla Skuldebrev med konvertering till B-aktier och nyemission av B-aktier till förväntat belopp om 2,75 miljarder kr
Share Issue/Capital Change Classification · 1% confidence The document is a press release from CELLINK AB dated March 11, 2021, announcing a major financing activity. The headline explicitly states: 'CELLINK AB (publ) offentliggör ett erbjudande av Seniora Icke-Säkerställda Konvertibla Skuldebrev med konvertering till B-aktier och en nyemission av B-aktier till förväntat belopp om 2,75 miljarder kr' (CELLINK AB (publ) announces an offering of Senior Unsecured Convertible Bonds convertible into Class B shares and a new issue of Class B shares for an expected amount of SEK 2.75 billion). The content details the terms of the Convertible Bonds and the directed new share issue (Nyemissionen), including coupon rates, conversion premiums, use of proceeds (financing an acquisition), and the need for shareholder approval (Aktieägarbeslutet) at an upcoming AGM. This clearly falls under the category of updates on company fundraising, financing activities, or capital structure changes. Based on the definitions, this aligns perfectly with 'Capital/Financing Update' (Code: CAP). It is not an ER (Earnings Release), 10-K (Annual Report), or IR (Interim Report), but a specific announcement about raising capital through debt and equity.
2021-03-11 Swedish
Cellink AB announces an offering of Senior Unsecured Convertible Bonds convertible into Class B shares and a Class B share issue in an expected amount of SEK 2.75 billion
Share Issue/Capital Change Classification · 1% confidence The document is an announcement dated March 11, 2021, detailing Cellink AB's plan to conduct an 'offering of Senior Unsecured Convertible Bonds' and a concurrent 'Class B share issue' totaling SEK 2.75 billion. This clearly describes a corporate financing activity involving the issuance of debt convertible into equity and a direct share placement. This aligns directly with the definition of 'Capital/Financing Update' (CAP). Although it mentions a future 'Shareholder Resolution' (which relates to AGM/Voting), the primary purpose and content of this announcement is the financing structure itself.
2021-03-11 English
CELLINK har ingått avtal om att förvärva MatTek, det världsledande bolaget inom in vitro-teknologi och alternativa testmetoder för läkemedel
M&A Activity Classification · 1% confidence The document is a press release dated March 10, 2021, announcing that CELLINK AB has entered into an agreement to acquire MatTek Corporation for $68 million. The content details the strategic rationale, transaction structure (cash and share consideration), expected closing date (March 24, 2021), and financial impact (consolidation starting Q2 2021). This type of announcement, detailing a significant corporate transaction like an acquisition, is best classified as a Capital/Financing Update (CAP) as it directly relates to a major change in the company's structure and financing (issuing new shares as part of the consideration). While it could potentially be RNS (Regulatory Filings) as a general announcement, CAP is more specific to financing/capital structure changes resulting from the deal. It is not an Earnings Release (ER), Interim Report (IR), or Annual Report (10-K).
2021-03-10 Swedish

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.